Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

NCT07455578 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases
Rheumatoid Arthritis (RA)
Psoriatic Arthritis (PsA)
Psoriasis (PsO)
Cutaneous Lupus Erythematosus (CLE)
Atopic Dermatitis (AD)

Interventions

DRUG: S-4321

Sponsor

Seismic Therapeutic AU Pty Ltd

Collaborators

[object Object]